| 08/02 | SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an.. | AQ |
| 08/02 | SAGE THERAPEUTICS : Announces Second Quarter 2022 Financial Results and Highlights Pipelin.. | PU |
| 08/02 | Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeli.. | BU |
| 08/01 | Sage Therapeutics to Present at Upcoming August Investor Conferences | BU |
| 07/19 | Sage Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 2,.. | BU |
| 07/14 | SAGE THERAPEUTICS : IF YOU DO NOT OBJECT TO THE PROPOSED SETTLEMENT, OR THE AGREED-TO ATTO.. | PU |
| 07/14 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 06/21 | SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matters.. | AQ |
| 06/13 | SAGE THERAPEUTICS, INC. : Other Events (form 8-K) | AQ |
| 06/02 | Sage Therapeutics to Present at Upcoming June Investor Conferences | BU |
| 06/01 | SAGE THERAPEUTICS : and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Po.. | PU |
| 06/01 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 06/01 | Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in P.. | BU |
| 05/04 | Sage Therapeutics to Present at Bank of America Securities 2022 Healthcare Conference | BU |
| 05/03 | SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an.. | AQ |
| 05/03 | Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipelin.. | BU |
| 05/02 | Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) .. | BU |
| 04/19 | Sage Therapeutics to Report First Quarter 2022 Financial Results on Tuesday, May 3, 202.. | BU |
| 04/04 | Sage Therapeutics Announces Presentation of Promising Results from the Phase 2 LUMINARY.. | AQ |
| 04/01 | Sage Therapeutics Announces Presentation of Promising Results from the Phase 2 LUMINARY.. | BU |
| 03/22 | Sage Therapeutics to Present at 2022 Stifel CNS Days | BU |
| 03/15 | Sage Therapeutics Announces Presentation of Encouraging Results from the Phase 2 PARADI.. | BU |
| 02/28 | Sage Therapeutics to Present at the Cowen 42nd Annual Healthcare Conference | BU |
| 02/24 | SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an.. | AQ |
| 02/24 | SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2021 Financial Results and High.. | PU |
| 02/24 | Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Hig.. | BU |
| 02/17 | Sage Therapeutics and Biogen Announce the Phase 3 CORAL Study Met its Primary and Key S.. | AQ |
| 02/16 | SAGE THERAPEUTICS : and Biogen Announce the Phase 3 CORAL Study Met its Primary and Key Se.. | PU |
| 02/16 | Sage Therapeutics and Biogen Announce the Phase 3 CORAL Study Met its Primary and Key S.. | BU |
| 02/16 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 02/10 | Sage Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on Thur.. | BU |
| 01/10 | SAGE THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (for.. | AQ |
| 01/04 | Sage Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on Tu.. | BU |
| 2021 | Sage Therapeutics Third Annual FutureCast Showcases Data from All Three Brain Health Fr.. | AQ |
| 2021 | Sage Therapeutics' Third Annual FutureCast Showcases Data from All Three Brain Health F.. | BU |
| 2021 | Sage Therapeutics and Biogen Announce New Analyses from the LANDSCAPE Clinical Developm.. | AQ |
| 2021 | SAGE THERAPEUTICS : and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the On.. | PU |
| 2021 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Sage Therapeutics to Host Sage FutureCast Webcast | BU |
| 2021 | Sage Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confer.. | BU |
| 2021 | Sage Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference | BU |
| 2021 | Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipelin.. | PU |
| 2021 | SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an.. | AQ |
| 2021 | Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipelin.. | BU |
| 2021 | SAGE THERAPEUTICS : to Report Third Quarter 2021 Financial Results on Tuesday, November 2,.. | BU |
| 2021 | SAGE THERAPEUTICS : and Biogen Announce Plans to Submit a New Drug Application (NDA) for Z.. | AQ |
| 2021 | SAGE THERAPEUTICS : and Biogen Announce Plans to Submit a New Drug Application (NDA) for Z.. | PU |
| 2021 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | SAGE THERAPEUTICS : and Biogen Announce Consistent Clinically Meaningful Data for Zuranolo.. | BU |
| 2021 | SAGE THERAPEUTICS : Launches SageCitizen Social Impact Initiative | BU |
| 2021 | SAGE THERAPEUTICS : Appoints Chris Benecchi as Chief Commercial Officer | BU |
| 2021 | SAGE THERAPEUTICS : Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt.. | AQ |
| 2021 | SAGE THERAPEUTICS : Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt.. | BU |
| 2021 | SAGE THERAPEUTICS : to Present at the Morgan Stanley Global Healthcare Conference | BU |
| 2021 | SAGE THERAPEUTICS : to Present at Upcoming August Investor Conferences | BU |
| 2021 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result.. | AQ |
| 2021 | SAGE THERAPEUTICS : Company announces REDWOOD and RAINFOREST Studies not expected to be re.. | PU |
| 2021 | SAGE THERAPEUTICS : Announces Second Quarter 2021 Financial Results and Highlights Pipelin.. | BU |
| 2021 | SAGE THERAPEUTICS : to Report Second Quarter 2021 Financial Results on Tuesday, August 3, .. | BU |
| 2021 | SAGE THERAPEUTICS : to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc.. | AQ |
| 2021 | SAGE THERAPEUTICS : to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc.. | BU |
| 2021 | SAGE THERAPEUTICS : to Participate in SVB Leerink's 3rd Annual CNS Forum | AQ |
| 2021 | SAGE THERAPEUTICS : to Participate in SVB Leerink's 3rd Annual CNS Forum | BU |
| 2021 | Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone f.. | AQ |
| 2021 | SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone an.. | AQ |
| 2021 | Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise | AQ |
| 2021 | SAGE THERAPEUTICS : to Host Conference Call | BU |
| 2021 | SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, a.. | PU |
| 2021 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 2021 | SAGE THERAPEUTICS : Joins MTV Entertainment Group and More Than 1,300 Leading Organization.. | BU |
| 2021 | SAGE THERAPEUTICS TO HOST SAGE SCIEN : SAGE-718 In Depth | BU |
| 2021 | SAGE THERAPEUTICS : Company on-track to initiate placebo-controlled Phase 2 trial with SAG.. | PU |
| 2021 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result.. | AQ |
| 2021 | SAGE THERAPEUTICS : Announces First Quarter 2021 Financial Results and Highlights Pipeline.. | BU |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
